STOCK TITAN

Endo Champions Men's Health Month with Education, Awareness, and Outreach

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags
Endo (OTCQX: NDOI) has launched a comprehensive Men's Health Month initiative for June 2025, focusing on raising awareness and education about men's health issues. The campaign targets underdiagnosed and stigmatized conditions including Peyronie's disease, erectile dysfunction, and testosterone deficiency. Key activities include digital outreach through social media, educational materials distribution in healthcare settings, email campaigns with clinical insights, and website content development. The company will participate in Wear Blue Day on June 13 to support men's health awareness. Justin Mattice, SVP & GM of Branded Specialty, emphasized the importance of empowering men to take an active role in their health management through proper information and awareness.
Endo (OTCQX: NDOI) ha lanciato un'iniziativa completa per il Mese della Salute Maschile di giugno 2025, con l'obiettivo di aumentare la consapevolezza e l'educazione sui problemi di salute maschile. La campagna si concentra su condizioni spesso sottodiagnosticate e stigmatizzate, come la malattia di Peyronie, la disfunzione erettile e la carenza di testosterone. Le attività principali includono la diffusione digitale tramite i social media, la distribuzione di materiali educativi nelle strutture sanitarie, campagne email con approfondimenti clinici e lo sviluppo di contenuti sul sito web. L'azienda parteciperà al Wear Blue Day il 13 giugno per sostenere la consapevolezza sulla salute maschile. Justin Mattice, SVP e GM di Branded Specialty, ha sottolineato l'importanza di dare agli uomini gli strumenti per gestire attivamente la propria salute attraverso informazioni corrette e consapevolezza.
Endo (OTCQX: NDOI) ha lanzado una iniciativa integral para el Mes de la Salud Masculina en junio de 2025, enfocada en aumentar la conciencia y la educación sobre los problemas de salud masculina. La campaña se dirige a condiciones subdiagnosticadas y estigmatizadas, como la enfermedad de Peyronie, la disfunción eréctil y la deficiencia de testosterona. Las actividades clave incluyen difusión digital a través de redes sociales, distribución de materiales educativos en centros de salud, campañas por correo electrónico con información clínica y desarrollo de contenido web. La compañía participará en el Wear Blue Day el 13 de junio para apoyar la concienciación sobre la salud masculina. Justin Mattice, SVP y GM de Branded Specialty, destacó la importancia de empoderar a los hombres para que tomen un papel activo en el manejo de su salud mediante información adecuada y conciencia.
Endo(OTCQX: NDOI)는 2025년 6월 남성 건강의 달을 맞아 남성 건강 문제에 대한 인식 제고와 교육에 중점을 둔 종합 캠페인을 시작했습니다. 이 캠페인은 페이로니병, 발기부전, 테스토스테론 결핍 등 진단이 부족하고 사회적 낙인이 찍힌 질환들을 대상으로 합니다. 주요 활동으로는 소셜 미디어를 통한 디지털 홍보, 의료기관 내 교육 자료 배포, 임상 정보를 담은 이메일 캠페인, 웹사이트 콘텐츠 개발이 포함됩니다. 회사는 6월 13일 남성 건강 인식 지원을 위한 Wear Blue Day에도 참여할 예정입니다. Justin Mattice 브랜디드 스페셜티 부사장 겸 총괄 매니저는 올바른 정보와 인식을 통해 남성들이 자신의 건강 관리를 적극적으로 할 수 있도록 권한을 부여하는 것이 중요하다고 강조했습니다.
Endo (OTCQX : NDOI) a lancé une initiative complète pour le Mois de la Santé Masculine en juin 2025, visant à sensibiliser et à éduquer sur les problématiques de santé des hommes. La campagne cible des affections souvent sous-diagnostiquées et stigmatisées, telles que la maladie de La Peyronie, la dysfonction érectile et la déficience en testostérone. Les activités clés comprennent une diffusion digitale via les réseaux sociaux, la distribution de supports éducatifs dans les établissements de santé, des campagnes par email avec des informations cliniques, ainsi que le développement de contenus sur le site web. L'entreprise participera à la Journée Wear Blue le 13 juin pour soutenir la sensibilisation à la santé masculine. Justin Mattice, SVP et GM de Branded Specialty, a souligné l'importance de donner aux hommes les moyens de prendre un rôle actif dans la gestion de leur santé grâce à une information et une sensibilisation appropriées.
Endo (OTCQX: NDOI) hat für Juni 2025 eine umfassende Initiative zum Monat der Männergesundheit gestartet, die sich auf die Sensibilisierung und Aufklärung über Männergesundheitsthemen konzentriert. Die Kampagne richtet sich auf oft unterdiagnostizierte und stigmatisierte Erkrankungen wie Peyronie-Krankheit, erektile Dysfunktion und Testosteronmangel. Zu den Hauptaktivitäten gehören digitale Reichweite über soziale Medien, Verteilung von Informationsmaterialien in Gesundheitseinrichtungen, E-Mail-Kampagnen mit klinischen Einblicken und die Entwicklung von Website-Inhalten. Das Unternehmen wird am 13. Juni am Wear Blue Day teilnehmen, um das Bewusstsein für Männergesundheit zu unterstützen. Justin Mattice, SVP & GM von Branded Specialty, betonte die Bedeutung, Männer durch richtige Informationen und Bewusstsein zu befähigen, eine aktive Rolle bei der Gesundheitsvorsorge zu übernehmen.
Positive
  • None.
Negative
  • None.

MALVERN, Pa., June 2, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today its Men's Health Month initiative, reaffirming its commitment to advancing men's health and addressing health issues affecting men.

Throughout the month of June, Endo is spearheading a range of activities designed to empower men to take charge of their physical, mental, and sexual health. The effort also aims to raise awareness among healthcare providers and patients about commonly underdiagnosed and stigmatized conditions such as Peyronie's disease, erectile dysfunction and testosterone deficiency.

Key components of the campaign include:

  • Targeted digital outreach through social media and online ads to engage men where they consume information
  • Educational materials distributed in healthcare settings to support patients and healthcare providers
  • Email campaigns sharing the latest clinical insights with healthcare providers
  • Website stories on endo.com featuring insights for providers and men on prioritizing and managing men's health

"Men may not always be the strongest advocates for their own health, but with the right information and awareness, we can empower them to take a more active role in their well-being," said Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo. "At Endo, we offer a unique portfolio of men's health products and equip healthcare providers with tools and education so they can support their patients in their health journey."

In support of the national effort, Endo will also participate in Wear Blue Day on June 13, a symbolic initiative encouraging individuals and organizations to wear blue to raise awareness of men's health issues.

For more information about Endo's initiatives and resources for Men's Health Month, visit the men's health section of endo.com.

About Men's Health Month
Men's Health Month is observed every June to raise awareness about health issues that specifically affect men. The initiative emphasizes the importance of early detection, preventive care, and effective treatment, encouraging men to take proactive steps toward managing their overall health and well-being.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements including, but not limited to, the statements by Mr. Mattice and any statements relating to product efficacy, potential treatments or indications, therapeutic outcomes or treatment responses, and any statements that refer to expected, estimated or anticipated future results or that do not relate solely to historical facts. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intends," "guidance," "future," "potential" or similar expressions are forward-looking statements. Because these statements reflect Endo's current views, expectations and beliefs concerning future events, they involve risks and uncertainties, some of which Endo may not currently be able to predict. Although Endo believes that these forward-looking statements and other information are based upon reasonable assumptions and expectations, readers should not place undue reliance on these or any other forward-looking statements and information. Actual results may differ materially and adversely from current expectations based on a number of factors, including, among other things, the following: changes in competitive, market or regulatory conditions; changes in legislation or regulations; the ability to obtain and maintain adequate protection for intellectual property rights; the impacts of competition; the timing and uncertainty of the results of the research and development and the regulatory processes; health care and cost containment reforms, including government pricing, tax and reimbursement policies; litigation and other disputes; consumer and physician acceptance of current and new products; the performance of third parties upon whom we rely for goods and services; issues associated with our supply chain; the ability to develop and expand our product pipeline, to launch new products and to continue to develop the market for our products; and the effectiveness of advertising and other promotional campaigns. Endo assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws. Additional information concerning risk factors, including those referenced above, can be found in press releases issued by Endo and in Endo's public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in Endo's most recent Form 10-K and Form 10-Q.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-champions-mens-health-month-with-education-awareness-and-outreach-302469557.html

SOURCE Endo, Inc.

FAQ

What is Endo's Men's Health Month initiative for 2025?

Endo's Men's Health Month initiative includes digital outreach, educational materials distribution, email campaigns with clinical insights, and website content development to raise awareness about men's health issues like Peyronie's disease, erectile dysfunction, and testosterone deficiency.

When is Wear Blue Day 2025 for men's health awareness?

Wear Blue Day will be observed on June 13, 2025, as part of Men's Health Month awareness initiatives.

What health conditions is Endo (NDOI) focusing on during Men's Health Month?

Endo is focusing on commonly underdiagnosed and stigmatized conditions including Peyronie's disease, erectile dysfunction, and testosterone deficiency.

How is Endo (NDOI) promoting men's health awareness in 2025?

Endo is promoting men's health awareness through social media outreach, healthcare setting educational materials, clinical insight email campaigns, and website content on endo.com.
Endo Inc

OTC:NDOI

NDOI Rankings

NDOI Latest News

NDOI Stock Data

1.92B
67.47M
55.75%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Malvern